Regenerative Medicine and Stem Cells Technologies

A new report published by Bostons Institute for Clinical and Economic Review (ICER) concludes that two pricey new CAR-T cell therapies, Novartis AGs Kymriah (tisagenlecleucel) and Gilead Sciences Inc.s Yescarta (axicabtagene ciloleucel), both provided moderate certainty of a small to substantial net health benefit compared to commonly used chemotherapies or no therapy at all in their respective indications.

Time heals all wounds – or so the saying goes. But our ability to heal damaged organs or tissues, such as the skin, is by no means perfect and results in formation of a scar. Scars are more fragile and less elastic than undamaged skin, and they lack hair follicles, sebaceous glands and sweat glands as these do not regenerate. In particular, large wounds like those caused by burns can lead to serious functional and cosmetic impairments.

Doctors on Sunday hailed what they say is a major breakthrough in the treatment of multiple sclerosis, halting progress of the disease and relieving symptoms in some patients.

When NASA astronaut Scott Kelly stood up last March after spending a year in space, he was two inches taller than his identical twin brother Mark.

British physicians have successfully used stem cells to repair the degenerating tissue at the back of two patients eyes in a world first, effectively reversing their diminishing eyesight.

An estimated 30.7% of Americans report chronic pain (chronic, recurrent, or long-lasting pain lasting at least 6 months) [1], making it an incredibly common and poorly treated disease state.

Professor Ali Khademhosseini is the recipient of the 2018 Acta Biomaterialia Silver Medal. He is Professor of Medicine at Harvard Medical School and Director of the Biomaterials Innovation Research Center at Brigham and Women’s Hospital. He is also a Faculty member at the Harvard-MIT Division of Health Sciences and Technology as well as an Associate Faculty member at the Wyss Institute for Biologically Inspired Engineering.

A pharmaceutical company based in Osaka, Japan, opened a regenerative medicine center yesterday (March 22) that will produce cells derived from induced pluripotent stem (iPS) cells for commercial applications. The center is the first plant of its kind globally. It will initially produce cells for use in clinical trials.

In its ninth year, The International Théophile Legrand Textile Innovation Awards are being under the auspices of the Fondation de France and coordinated by the Union des Industries Textiles (UIT), the union of textile industries, the employers association representing the diversity of French textile sections and regions. In 2018, two prizes of € 8,000 and € 7,000 will be presented to those textile projects considered to be the most innovative.

The closing ceremony of the second student Olympiad on stem cells and regenerative medicine was held in the Vice-Presidency for science and technology affairs and the winners were awarded